Literature DB >> 2446442

Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease.

M G Mateu1, E Rocha, O Vicente, F Vayreda, C Navalpotro, D Andreu, E Pedroso, E Giralt, L Enjuanes, E Domingo.   

Abstract

A panel of 12 monoclonal antibodies (MAbs) raised against foot-and-mouth disease virus (FMDV) of serotype C1 (FMDV C-S8c1) and 11 MAbs raised against other FMDVs have been used to evaluate the reactivity of 14 isolates of FMDV of serotype C1 (series FMDV C-S), 12 of them from one disease episode (Spain 1979-1982). The assays used were immunoelectrotransfer blot, immunodot and neutralization of infectivity. None of the isolates could be clearly distinguished by its reactivity with 6 non-neutralizing and 2 neutralizing MAbs raised against FMDV C-S8c1. In contrast, the isolates were distinguished in two groups by a 10(2)-fold difference in their reactivity with 6 neutralizing MAbs. The reactivity of MAbs with synthetic peptides indicated that conserved and non-conserved epitopes recognised respectively by neutralizing MAbs 4G3 and SD6 are localized in the immunogenic region (amino acids 138-156) of VP1. Thus, epidemiologically related FMDVs differ in at least one epitope critical for virus neutralization.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446442     DOI: 10.1016/0168-1702(87)90020-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  33 in total

1.  Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies.

Authors:  M A Martínez; C Carrillo; F González-Candelas; A Moya; E Domingo; F Sobrino
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

Review 2.  Molecular evolution of aphthoviruses.

Authors:  E Domingo; M G Mateu; C Escarmís; E Martínez-Salas; D Andreu; E Giralt; N Verdaguer; I Fita
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

3.  The foot and mouth disease virus type O outbreak of 1992 is not related to vaccine strain (O/R2/75).

Authors:  V Suryanarayana; P Tulasiram; K S Prabhudas; L D Misra; C Natarajan
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

4.  A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.

Authors:  O Taboga; C Tami; E Carrillo; J I Núñez; A Rodríguez; J C Saíz; E Blanco; M L Valero; X Roig; J A Camarero; D Andreu; M G Mateu; E Giralt; E Domingo; F Sobrino; E L Palma
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Co-expression of the Bcl-xL antiapoptotic protein enhances the induction of Th1-like immune responses in mice immunized with DNA vaccines encoding FMDV B and T cell epitopes.

Authors:  Sultan Gülçe İz; Mert Döşkaya; Belen Borrego; Fernando Rodriguez; Yüksel Gürüz; Ismet Deliloğlu Gürhan
Journal:  Vet Res Commun       Date:  2013-03-13       Impact factor: 2.459

6.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid lability and confer resistance to acid-dependent uncoating inhibition.

Authors:  Miguel A Martín-Acebes; Verónica Rincón; Rosario Armas-Portela; Mauricio G Mateu; Francisco Sobrino
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

8.  Emergence of a new strain of type O foot-and-mouth disease virus: its phylogenetic and evolutionary relationship with the PanAsia pandemic strain.

Authors:  Divakar Hemadri; Chakradhar Tosh; Aniket Sanyal; Ramamurthy Venkataramanan
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

9.  Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3' noncoding region can elicit immunity in swine.

Authors:  Miguel Rodríguez Pulido; Francisco Sobrino; Belén Borrego; Margarita Sáiz
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

10.  New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines.

Authors:  Teresa Rodríguez-Calvo; Samuel Ojosnegros; Marta Sanz-Ramos; Juan García-Arriaza; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.